Suppr超能文献

相似文献

1
Reduced neurofilament expression in cutaneous nerve fibers of patients with CMT2E.
Neurology. 2015 Jul 21;85(3):228-34. doi: 10.1212/WNL.0000000000001773. Epub 2015 Jun 24.
2
Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton.
Brain. 2007 Feb;130(Pt 2):394-403. doi: 10.1093/brain/awl284. Epub 2006 Oct 18.
4
Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E.
Exp Neurol. 2018 Oct;308:13-25. doi: 10.1016/j.expneurol.2018.06.010. Epub 2018 Jun 22.
5
Charcot-Marie-Tooth disease Type 2E/1F mutant neurofilament proteins assemble into neurofilaments.
Cytoskeleton (Hoboken). 2019 Jul;76(7-8):423-439. doi: 10.1002/cm.21566. Epub 2019 Nov 6.
6
Muscle pathology without severe nerve pathology in a new mouse model of Charcot-Marie-Tooth disease type 2E.
Hum Mol Genet. 2011 Jul 1;20(13):2535-48. doi: 10.1093/hmg/ddr152. Epub 2011 Apr 14.
7
Abnormal neurofilament inclusions and segregations in dorsal root ganglia of a Charcot-Marie-Tooth type 2E mouse model.
PLoS One. 2017 Jun 27;12(6):e0180038. doi: 10.1371/journal.pone.0180038. eCollection 2017.
9
Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B.
Neurology. 2006 Oct 10;67(7):1141-6. doi: 10.1212/01.wnl.0000238499.37764.b1.
10
Effect of an R69C mutation in the myelin protein zero gene on myelination and ion channel subtypes.
Arch Neurol. 2006 Dec;63(12):1787-94. doi: 10.1001/archneur.63.12.1787.

引用本文的文献

3
Clinical Outcome Assessments and Biomarkers in Charcot-Marie-Tooth Disease.
Neurology. 2024 Dec 24;103(12):e210120. doi: 10.1212/WNL.0000000000210120. Epub 2024 Nov 25.
4
Current Treatment Methods for Charcot-Marie-Tooth Diseases.
Biomolecules. 2024 Sep 9;14(9):1138. doi: 10.3390/biom14091138.
5
Charcot-Marie-Tooth type 2CC misdiagnosed as Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Neurol Sci. 2024 Dec;45(12):5933-5937. doi: 10.1007/s10072-024-07747-7. Epub 2024 Sep 3.
7
Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies.
Front Neurosci. 2021 Sep 27;15:689938. doi: 10.3389/fnins.2021.689938. eCollection 2021.
8
Charcot-Marie-Tooth disease type 2CC due to variants causes a progressive, non-length-dependent, motor-predominant phenotype.
J Neurol Neurosurg Psychiatry. 2022 Jan;93(1):48-56. doi: 10.1136/jnnp-2021-327186. Epub 2021 Sep 13.
9
A review and analysis of the clinical literature on Charcot-Marie-Tooth disease caused by mutations in neurofilament protein L.
Cytoskeleton (Hoboken). 2021 Mar;78(3):97-110. doi: 10.1002/cm.21676. Epub 2021 Jun 3.
10
New evidence for secondary axonal degeneration in demyelinating neuropathies.
Neurosci Lett. 2021 Jan 23;744:135595. doi: 10.1016/j.neulet.2020.135595. Epub 2020 Dec 24.

本文引用的文献

2
Charcot-Marie-Tooth disease: frequency of genetic subtypes in a Southern Italy population.
J Peripher Nerv Syst. 2014 Dec;19(4):292-8. doi: 10.1111/jns.12092.
6
Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens.
Neuropathol Appl Neurobiol. 2012 Oct;38(6):591-601. doi: 10.1111/j.1365-2990.2012.01250.x.
7
Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease.
J Peripher Nerv Syst. 2011 Sep;16(3):191-8. doi: 10.1111/j.1529-8027.2011.00350.x.
9
Muscle pathology without severe nerve pathology in a new mouse model of Charcot-Marie-Tooth disease type 2E.
Hum Mol Genet. 2011 Jul 1;20(13):2535-48. doi: 10.1093/hmg/ddr152. Epub 2011 Apr 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验